The Ameriprise Financial Inc. sells partial stakes of Bruker Corp. (BRKR)

The Ameriprise Financial Inc. sells partial stakes of Bruker Corp. (BRKR)

Ameriprise Financial Inc. reduced its stake in Bruker Corp. (NASDAQ:BRKR) by 3.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 247,445 shares of the company’s stock after selling 9,877 shares during the period. Ameriprise Financial Inc. owned approximately 0.15% of Bruker Corp. worth $5,628,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Societe Generale acquired a new stake in shares of Bruker Corp. during the second quarter valued at $135,000. Natixis acquired a new stake in shares of Bruker Corp. during the first quarter valued at $248,000. Bank of Hawaii boosted its stake in shares of Bruker Corp. by 23.6% in the second quarter. Bank of Hawaii now owns 9,150 shares of the company’s stock valued at $208,000 after buying an additional 1,750 shares during the last quarter. New York State Teachers Retirement System acquired a new stake in shares of Bruker Corp. during the second quarter valued at $218,000. Finally, Seven Eight Capital LLC acquired a new stake in shares of Bruker Corp. during the first quarter valued at $319,000. 69.92% of the stock is owned by hedge funds and other institutional investors.

Shares of Bruker Corp. (NASDAQ:BRKR) traded down 0.24% during mid-day trading on Thursday, reaching $20.91. 303,898 shares of the company were exchanged. Bruker Corp. has a 12 month low of $16.99 and a 12 month high of $29.85. The stock has a market capitalization of $3.37 billion, a P/E ratio of 31.49 and a beta of 0.93. The stock has a 50 day moving average price of $22.25 and a 200-day moving average price of $24.74.

Bruker Corp. (NASDAQ:BRKR) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.20 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.20. The business had revenue of $371.70 million for the quarter, compared to analyst estimates of $409.57 million. Bruker Corp. had a net margin of 6.86% and a return on equity of 22.66%. The company’s revenue was down 6.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.19 EPS. Analysts predict that Bruker Corp. will post $1.00 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 23rd. Stockholders of record on Tuesday, September 6th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Thursday, September 1st. This represents a $0.16 annualized dividend and a dividend yield of 0.76%. Bruker Corp.’s payout ratio is currently 24.24%.

Several research analysts recently commented on the stock. Zacks Investment Research lowered shares of Bruker Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Morgan Stanley set a $23.00 price objective on shares of Bruker Corp. and gave the stock a “hold” rating in a research note on Wednesday, August 3rd. Mizuho reduced their price objective on shares of Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating for the company in a research note on Wednesday, August 3rd. Barclays PLC reduced their price objective on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, August 3rd. Finally, Cleveland Research lowered shares of Bruker Corp. from a “buy” rating to a “neutral” rating in a research note on Friday, July 22nd. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $25.80.

In related news, Director Richard A. Packer acquired 10,000 shares of the business’s stock in a transaction dated Wednesday, August 10th. The shares were acquired at an average cost of $21.97 per share, for a total transaction of $219,700.00. Following the acquisition, the director now directly owns 22,500 shares in the company, valued at approximately $494,325. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Frank H. Laukien acquired 4,500 shares of the business’s stock in a transaction dated Friday, August 5th. The shares were bought at an average price of $22.17 per share, for a total transaction of $99,765.00. Following the completion of the acquisition, the chief executive officer now owns 37,658,733 shares in the company, valued at $834,894,110.61. The disclosure for this purchase can be found here. Insiders own 35.80% of the company’s stock.

Bruker Corp. Company Profile

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Related posts

Leave a Comment